Browsing: Eli

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025.In a significant move aimed at broadening access…

Novo Nordisk is undergoing significant leadership changes as it grapples with intensifying competition and a sharp decline in its market…

In a recent statement, Dave Ricks, CEO of Eli Lilly and Company, addressed national security concerns surrounding the importation of…

Eli Lilly has recently announced financial results for the first quarter, showcasing significant growth driven by its popular diabetes and…

In the world of finance this week, major companies have reported their latest earnings, spurring fluctuations in stock prices across…

Eli Lilly, the pharmaceutical giant known for its weight loss drug Zepbound and diabetes treatment Mounjaro, has initiated legal action…

Eli Lilly and Co. has announced a major milestone in diabetes treatment with the success of its Phase 3 clinical…

Eli Lilly, a prominent biopharmaceutical company, has initiated legal action against two compounding pharmacies in an effort to protect its…

Eli Lilly is poised to potentially revolutionize the weight loss drug market with the upcoming introduction of orforglipron, a once-daily…

Eli Lilly, a major player in the pharmaceutical industry, announced on Wednesday its plans to invest at least $27 billion…